Vivan Therapeutics

Vivan Therapeutics supports cancer patients & their clinicians by identifying ultra-personalised therapeutic solutions, while also assisting with clinical trial direction, drug discovery & development. 

Vivan utilises a comprehensive, genomics-based drug screening technology developed at and licensed in partnership with the Icahn School of medicine, Mount Sinai Medical Center. 

Using its proprietary drug-screening data, Vivan has built a powerful digital-health tool, TuMatch, which uses AI/machine learning to match a cancer patient’s DNA to personalized treatment recommendations.